| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | N06BX06 |
| UNII: | 536BQ2JVC7 |
| InChI Key | RZZPDXZPRHQOCG-OJAKKHQRSA-O |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H26N4O11P2 |
| Molecular Weight | 488.33 |
| AlogP | -2.23 |
| Hydrogen Bond Acceptor | 13.0 |
| Hydrogen Bond Donor | 4.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 215.72 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 31.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 70 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Stroke | 3 | D020521 | ClinicalTrials |
| Amphetamine-Related Disorders | 3 | D019969 | ClinicalTrials |
| Brain Ischemia | 3 | D002545 | ClinicalTrials |
| Brain Injuries | 3 | D001930 | ClinicalTrials |
| Cerebral Infarction | 3 | D002544 | ClinicalTrials |
| Marijuana Abuse | 2 | D002189 | ClinicalTrials |
| Ischemic Stroke | 1 | D000083242 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 987-78-0 |
| ChEBI | 16436 |
| ChEMBL | CHEMBL1231700 |
| DrugBank | DB12153 |
| DrugCentral | 664 |
| FDA SRS | 536BQ2JVC7 |
| Human Metabolome Database | HMDB0001413 |
| KEGG | C00307 |
| PDB | CDC |
| PubChem | 13804 |
| SureChEMBL | SCHEMBL221081 |
| CAS NUMBER | 987-78-0 |
| ChEBI | 49086 |
| ChEMBL | CHEMBL1618340 |
| EPA CompTox | DTXSID9048431 |
| FDA SRS | 536BQ2JVC7 |
| PubChem | 13804 |
| SureChEMBL | SCHEMBL8303928 |
| ZINC | ZINC000006507065 |